(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Ciencias Cardiovasculares > Cardiopatía hipertensiva > DA - CIMA - Cardiovasculares - Cardiopatía hipertensiva - Artículos de Revista >

Is plasma cardiotrophin-1 a marker of hypertensive heart disease?
Autor(es) : Lopez, B. (Begoña)
Gonzalez, A. (Arantxa)
Lasarte, J.J. (Juan José)
Sarobe, P. (Pablo)
Borras-Cuesta, F. (Francisco)
Diaz, A. (Agnes)
Barba, J. (Joaquín)
Tomas, L. (Lourdes)
Lozano, E. (Elisa)
Serrano, M. (Manuel)
Varo, N. (Nerea)
Beloqui, O. (Óscar)
Fortuño, M.A. (María Antonia)
Diez, J. (Javier)
Palabras clave : Cardiotrophin-1
Hypertensive heart disease
Left ventricular
Fecha incorporación: 2005
Editorial : Lippincott, Williams & Wilkins
Versión del editor: http://journals.lww.com/jhypertension/Abstract/2005/03000/Is_plasma_cardiotrophin_1_a_marker_of_hypertensive.24.aspx
ISSN: 0263-6352
Cita: Lopez B, Gonzalez A, Lasarte JJ, Sarobe P, Borras F, Diaz A, et al. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?. J Hypertens 2005 Mar;23(3):625-632.
Resumen
OBJECTIVE: This study was designed to investigate whether plasma concentration of cardiotrophin-1 (CT-1), a cytokine that induces cardiomyocyte hypertrophy and stimulates cardiac fibroblasts, is related to hypertensive heart disease, as defined by the presence of echocardiographically assessed left ventricular hypertrophy (LVH). METHODS: The study was performed in 31 normotensive subjects and 111 patients with never-treated essential hypertension (54 without LVH and 57 with LVH). Causes of LVH other than hypertension were excluded after a complete medical workup. A novel enzyme-linked immunosorbent assay was developed to measure plasma CT-1. RESULTS: Plasma CT-1 was increased (P < 0.001) in hypertensives compared with normotensives. The value of CT-1 was higher (P < 0.001) in hypertensives with LVH than in hypertensives without LVH. Some 31% of patients without LVH exhibited values of CT-1 above the upper normal limit in normotensives. A direct correlation was found between CT-1 and left ventricular mass index (r = 0.319, P < 0.001) in all subjects. Receiver operating characteristic curves showed that a cutoff of 39 fmol/ml for CT-1 provided 75% specificity and 70% sensitivity for predicting LVH with a relative risk of 6.21 (95% confidence interval, 2.95 to 13.09). CONCLUSIONS: These results show an association between LVH and the plasma concentration of CT-1 in essential hypertension. Although preliminary, these findings suggest that the determination of CT-1 may be an easy and reliable method for the initial screening and diagnosis of hypertensive heart disease.
Enlace permanente: http://hdl.handle.net/10171/19914
Aparece en las colecciones: DA - CIMA - Servicios de apoyo - Biobanco - Artículos de revista
DA - Medicina - Medicina Interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología experimental - Artículos de revista
DA - CIMA - Cardiovasculares - Cardiopatía hipertensiva - Artículos de Revista

Ficheros en este registro:
Fichero:  J Hypertens 23;625-632.pdf
Descripción: 
Tamaño:  227,02 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.